Silence Therapeutics plc
(NASDAQ: SLN)
|
5:00 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $17.97 | Change: -0.09 | %Change: -0.50% | Volume: 67,670 |
Open: | $ 18.28 | Volume: | 67,670 | |
---|---|---|---|---|
High: | $ 18.48 | Yield(%) | 0.00 | |
Low: | $ 17.57 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 841.16M | |
EPS ($) | -1.15 | Shares Out: | 46.58M |
% Price Change (last 4 weeks): | -8.97 |
---|---|
% Price Change (last 13 weeks): | -14.97 |
% Price Change (last 26 weeks): | -2.64 |
% Price Change (last 52 weeks): | 203.53 |
% Price Change (year to date): | 3.97 |
Return on Equity (%): | -222.77 |
---|---|
Return on Assets (%): | -43.21 |
Return on Invested Capital (%): | -242.87 |
Gross Profit Margin (%): | 59.20 |
---|---|
Net Profit Margin (%): | -170.51 |
Operating Profit Margin (%): | -195.48 |
|
|
50-day Moving Average: | $21.07 |
---|---|
200-day Moving Average: | $17.61 |
Avg. Daily Vol. (last 50 days): | 141,554 |
Avg. Daily Vol. (last 200 days): | 145,122 |
52-wk high: | $27.72 |
52-wk low: | $4.84 |
Bid: | $17.75 |
Ask: | $18.50 |
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
|
Silence Therapeutics plc
72 Hammersmith Road London GL W14 8TH Phone: 44.20.3457.6900 Fax: n/a http://www.silence-therapeutics.com |
Earnings (1year) ($): | -1.15 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.55 |
Cash Flow ($): | -1.34 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 20.43 |
Price/Book (x): | 31.66 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 4.56 |
---|---|
Current Ratio (x): | 4.56 |
LT Debt/Equity (x): | 0.55 |
Total Debt/Equity (x): | 1.60 |